EUPL 2027 BEGINS IN
- 00Days
- 00Hrs
- 00Mins
- 00Secs
18-20 May 2027
Steigenberger Icon Wiltcher's, Brussels, BE18-20 May 2027
Steigenberger Icon Wiltcher's, Brussels, BE
Steigenberger Icon Wiltcher's, Brussels, BE
Join Copenhagen Economics at EU Pharmaceutical Law Forum 2024
You're Invited to EU Pharma Law with an Exclusive 10% Off
We are excited to announce that Copenhagen Econmics will be participating at the EU Pharmaceutical Law Forum on 21-23 May 2024 at the Steigenberger Wiltcher's Hotel, Brussels. And, we are pleased to let you know that as a valued client of Copenhagen Econimcs, we have an exclusive 10% discount* for you. Your VIP discount code is: P24COPENHAGENECO
*T&C's Apply
Opening Remarks from Afternoon Chair
PANEL Market Access Challenges and Developments for Pharmaceutical Firms
- National developments for price transparency: recent decisions, legal issues and challenges
- Individual prices in tender decisions: to what extent do we need to make this transparent?
- Discounts and clawback schemes impacting reimbursement and turnover: German combination rebate, NHS VPAS scheme, schemes in France
- Latest trends & developments: HTA regulations - friend or foe?
Presented By:
PANEL Merger Control and Expanded Jurisdictional Reach Developments and Strategy
- Review of recent pharmaceutical merger control cases and authority approach
Article 22: the latest on Illumina/ Grail and implications for merger control strategy - Review of wider merger control cases: Pfizer/ Seagen and implications of Towercast judgments
- Comparison of EU developments to global trends in merger control
- How does merger control fit into overall regulatory scrutiny of the pharmaceutical industry?
- Practical commercial implications when planning for commercial deals